3688-46-8 Usage
Uses
Used in Pharmaceutical Industry:
4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID is used as a pharmaceutical compound for its ability to serve as a substrate or inhibitor in the carnitine acetyltransferase reaction. This dual functionality allows it to be a valuable asset in the development of drugs targeting metabolic processes and conditions related to carnitine deficiency or imbalance.
Used in Research and Development:
In the field of research and development, 4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID is used as a research tool for studying the carnitine acetyltransferase reaction and its role in various metabolic pathways. This understanding can lead to the development of novel therapeutic strategies and treatments for conditions related to carnitine metabolism.
Used in Nutritional Supplements:
4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID can be used as an ingredient in nutritional supplements, particularly those aimed at supporting energy metabolism and muscle function. As an analog and substitute for carnitine, it may help improve the transport of fatty acids into the mitochondria for energy production, thus potentially enhancing physical performance and recovery.
Used in Cosmetics Industry:
In the cosmetics industry, 4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID may find applications in the development of skincare and beauty products. Its role in energy metabolism could potentially be harnessed to improve skin health, reduce signs of aging, and promote overall skin rejuvenation.
Overall, 4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID is a versatile compound with a wide range of potential applications across various industries, including pharmaceuticals, research and development, nutritional supplements, and cosmetics. Its ability to act as both a substrate and an inhibitor in the carnitine acetyltransferase reaction makes it a valuable asset for the development of new therapies, products, and treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 3688-46-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,8 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3688-46:
(6*3)+(5*6)+(4*8)+(3*8)+(2*4)+(1*6)=118
118 % 10 = 8
So 3688-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO3/c1-7(2)4-5(8)3-6(9)10/h5,8H,3-4H2,1-2H3,(H,9,10)
3688-46-8Relevant academic research and scientific papers
METHOD OF PREPARING AN ALKYLAMINE DERIVATIVE
-
Page/Page column 6, (2012/03/10)
The present invention provides a method of preparing an alkylamine derivates which hardly generates impurities and enables mass production with high purity.
Asymmetric synthesis of (S)-(+)-carnitine and analogs
Jain, Rajendra P,Williams, Robert M
, p. 6505 - 6509 (2007/10/03)
A general asymmetric route to enantiomerically pure (S)-(+)-carnitine and analogs has been investigated that involves mono-addition of organometallic reagents to the lactone carbonyl group of (5R,6S)-4-(benzyloxycarbonyl)-5,6-diphenyl-2,3,5,6-tetrahydro-4H-1,4-oxazin- 2-one and Lewis acid promoted stereoselective allylation of the resulting hemiacetals. The diastereomerically pure allyl oxazines thus obtained were readily converted into enantiomerically pure (S)-(+)-carnitine and two substituted analogs.
Asymmetric synthesis of (R)-(-)-carnitine
Jain, Rajendra P.,Williams, Robert M.
, p. 4437 - 4440 (2007/10/03)
A TiCl4-promoted Mukaiyama-type aldol reaction of the ketenesilyl acetal of ethyl acetate with the lactone carbonyl of (5R,6S)-4-(benzyloxycarbonyl)-5,6-diphenyl-2,3,5,6-tetrahydro-4H-1,4-oxazin- 2-one (1) proceeds with a high degree of diastereoselectivity. The TBDMS-protected hemiketal thus obtained was efficiently converted into highly enantiomerically enriched (R)-(-)-carnitine by following an elimination-reduction protocol. This approach further demonstrates the utility of commercially available glycine template 1 as a potential substrate for the asymmetric synthesis of both enantiomers of carnitine.
